ICRIS Québec

Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison

Curtis M., Berk J., Larney S., Rich J., & Stoové M. J Public Health Policy. 2022 Mar;43(1):149-154. doi: 10.1057/s41271-021-00327-5. Epub 2022 Jan 8. PMID: 34997211 CONSULTER

Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison Lire la suite »

The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: A retrospective data linkage study

Colledge-Frisby, S., Jones, N., Larney, S., Peacock, A., Lewer, D., Brothers, T. D., Hickman, M., Farrell, M., & Degenhardt, L. Drug Alcohol Depend. 2022 Jul 1;236:109494. doi: 10.1016/j.drugalcdep.2022.109494. Epub 2022 May 13. PMID: 35605532. CONSULTER

The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: A retrospective data linkage study Lire la suite »

Selective personality-targeted prevention of suicidal ideation in young adolescents: post hoc analysis of data collected in a cluster randomised controlled trial

Grummitt, L.R., Debenham, J., Kelly, E.V., Barrett, E.L., Champion, K.E., Conrod, P.J., Teesson, M., & Newton, N.C. Med J Aust. 2022 Jun 6;216(10):525-529. doi: 10.5694/mja2.51536. Epub 2022 May 14. PMID: 35568380; PMCID: PMC9542662 CONSULTER

Selective personality-targeted prevention of suicidal ideation in young adolescents: post hoc analysis of data collected in a cluster randomised controlled trial Lire la suite »

Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial

Jutras-Aswad, D., Le Foll, B., Ahamad, K., Lim, R., Bruneau, J., Fischer, B., Rehm, J., Wild, C., Wood, E., Brissette, S., Gagnon, L., Fikowski, J., Ledjiar, O., Masse, B., Socias, E. American Journal of Psychiatry, Volume 179, Number 10, https://doi.org/10.1176/appi.ajp.21090964 CONSULTER

Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial Lire la suite »

Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial

Socias, E., Wood, E., Le Foll, B., Lim, R., Cheol Choi, J., Yin Mok, W., Bruneau, J., Rehm, J., Wild, C., Bozinoff, N., Hassan, A., Jutras-Aswad, D. Addiction. 2022 Oct;117(10):2662-2672. doi: 10.1111/add.15954. Epub 2022 Jun 17. PMID: 35712892; PMCID: PMC9969999. CONSULTER

Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial Lire la suite »